Admelog OverviewInsulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market. Engineered through recombinant DNA technology, the penultimate lysine and proline residues on the C-terminal end of the B-chain are reversed. This modification does not alter receptor binding, but blocks the formation of insulin dimers and hexamers. This allows lar...
Read more Admelog Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_lispro
Recent Admelog Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100 Units/ml, 100unit/ml, 200units/ml
- Solution: 1000 Units/10ml (100 Units/ml), 200 Units/ml, 300 Units/3ml (100 Units/ml)
NDC Database Records for Admelog: (2 results)Sorted by National Drug Code
- 0024-5924 Admelog 100 U/Ml Intravenous; Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
- 0024-5925 Admelog 100 U/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Other drugs which contain Insulin Lispro or a similar ingredient: (3 results)
- HUMALOG Insulin Lispro1 discussion
- INSULIN LISPRO 1 discussion
- INSULIN LISPRO + INSULIN LISPRO PROTAMINE